SummitTX Capital’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$140K Buy
+23,455
New +$176K ﹤0.01% 705
2025
Q3
Sell
-60,079
Closed -$582K 917
2025
Q2
$582K Sell
60,079
-18,333
-23% -$189K 0.03% 482
2025
Q1
$1.17M Buy
+78,412
New +$1.21M 0.05% 370

Other funds holding OGN

SummitTX Capital's OGN Position: Q1 2026 in Review

SummitTX Capital opened a new position in Organon & Co (OGN) in Q1 2026: 23,455 shares worth $140K. The stake represents ﹤0.01% of the portfolio and ranks #705 among its holdings. This is a return to the name: SummitTX Capital previously reported a position in OGN as recently as Q2 2025.

SummitTX Capital first reported a position in OGN in Q1 2025 and has held it in 3 quarters since. The position peaked at $1.17M in Q1 2025. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • SummitTX Capital held 23,455 shares of Organon & Co worth $140K as of Q1 2026.
  • Organon & Co was a new SummitTX Capital position in Q1 2026.
  • Organon & Co made up ﹤0.01% of SummitTX Capital's portfolio in Q1 2026, its #705 holding.
  • SummitTX Capital first reported a position in Organon & Co in Q1 2025 and has held it in 3 quarters since.
  • SummitTX Capital's Organon & Co position peaked at $1.17M in Q1 2025.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on SummitTX Capital's 13F filing for Q1 2026, filed 15 May 2026.